266 related articles for article (PubMed ID: 26613809)
1. Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes.
Peyvandi F; Rossio R; Ferrari B; Lotta LA; Pontiggia S; Ghiringhelli Borsa N; Pizzuti M; Donadelli R; Piras R; Cugno M; Noris M
J Thromb Haemost; 2016 Feb; 14(2):340-5. PubMed ID: 26613809
[TBL] [Abstract][Full Text] [Related]
2. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA
J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
[TBL] [Abstract][Full Text] [Related]
3. The role of von Willebrand factor in thrombotic microangiopathy.
Noone DG; Riedl M; Licht C
Pediatr Nephrol; 2018 Aug; 33(8):1297-1307. PubMed ID: 28748411
[TBL] [Abstract][Full Text] [Related]
4. Complement activation in diseases presenting with thrombotic microangiopathy.
Meri S
Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic thrombocytopenic purpura.
Lämmle B; Kremer Hovinga JA; Alberio L
J Thromb Haemost; 2005 Aug; 3(8):1663-75. PubMed ID: 16102032
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic approach to microangiopathic hemolytic disorders.
Kottke-Marchant K
Int J Lab Hematol; 2017 May; 39 Suppl 1():69-75. PubMed ID: 28447417
[TBL] [Abstract][Full Text] [Related]
8. Does severe ADAMTS13 deficiency in thrombotic microangiopathy rule out complement-mediated atypical hemolytic uremic syndrome.
Arumugam V; Bhowmick R; Agarwal I; Arumadi M
Saudi J Kidney Dis Transpl; 2019; 30(3):701-705. PubMed ID: 31249236
[TBL] [Abstract][Full Text] [Related]
9. A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity.
Rossio R; Lotta LA; Pontiggia S; Borsa NG; Garagiola I; Ardissino G; Mikovic D; Cugno M; Peyvandi F
Haematologica; 2015 Mar; 100(3):e87-9. PubMed ID: 25381125
[No Abstract] [Full Text] [Related]
10. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
Shenkman B; Einav Y
Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
[TBL] [Abstract][Full Text] [Related]
12. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.
Scully M; Cataland S; Coppo P; de la Rubia J; Friedman KD; Kremer Hovinga J; Lämmle B; Matsumoto M; Pavenski K; Sadler E; Sarode R; Wu H;
J Thromb Haemost; 2017 Feb; 15(2):312-322. PubMed ID: 27868334
[TBL] [Abstract][Full Text] [Related]
13. [Atypical HUS caused by complement-related abnormalities].
Yoshida Y; Matsumoto M
Rinsho Ketsueki; 2015 Feb; 56(2):185-93. PubMed ID: 25765799
[TBL] [Abstract][Full Text] [Related]
14. Von Willebrand factor regulates complement on endothelial cells.
Noone DG; Riedl M; Pluthero FG; Bowman ML; Liszewski MK; Lu L; Quan Y; Balgobin S; Schneppenheim R; Schneppenheim S; Budde U; James P; Atkinson JP; Palaniyar N; Kahr WH; Licht C
Kidney Int; 2016 Jul; 90(1):123-34. PubMed ID: 27236750
[TBL] [Abstract][Full Text] [Related]
15. The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico study.
Lancellotti S; Peyvandi F; Pagliari MT; Cairo A; Abdel-Azeim S; Chermak E; Lazzareschi I; Mastrangelo S; Cavallo L; Oliva R; De Cristofaro R
Thromb Haemost; 2016 Jan; 115(1):51-62. PubMed ID: 26272487
[TBL] [Abstract][Full Text] [Related]
16. Defining the genetics of thrombotic microangiopathies.
Vieira-Martins P; El Sissy C; Bordereau P; Gruber A; Rosain J; Fremeaux-Bacchi V
Transfus Apher Sci; 2016 Apr; 54(2):212-9. PubMed ID: 27177491
[TBL] [Abstract][Full Text] [Related]
17. Modified Ham test for atypical hemolytic uremic syndrome.
Gavriilaki E; Yuan X; Ye Z; Ambinder AJ; Shanbhag SP; Streiff MB; Kickler TS; Moliterno AR; Sperati CJ; Brodsky RA
Blood; 2015 Jun; 125(23):3637-46. PubMed ID: 25862562
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
Saha M; McDaniel JK; Zheng XL
J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310
[TBL] [Abstract][Full Text] [Related]
19. An extremely rare splice site mutation in the gene encoding complement factor I in a patient with atypical hemolytic uremic syndrome.
Ipe TS; Lim J; Reyes MA; Ero M; Leveque C; Lewis B; Kain J
J Clin Apher; 2017 Dec; 32(6):584-588. PubMed ID: 28455885
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency.
Fan X; Kremer Hovinga JA; Shirotani-Ikejima H; Eura Y; Hirai H; Honda S; Kokame K; Taleghani MM; von Krogh AS; Yoshida Y; Fujimura Y; Lämmle B; Miyata T
Int J Hematol; 2016 Mar; 103(3):283-91. PubMed ID: 26830967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
